Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 123
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06612814 | PARP Inhibitor With CDK4/ 6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer | ||
| NCT06699459 | Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC | ||
| NCT07176962 | A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening | ||
| NCT01337037 | Modified Video-assisted Thoracoscopic Surgery (VATS) Lobectomy for Early-stage Non-small Cell Lung Cancer (NSCLC) | ||
| NCT03357094 | Pulmonary Ventilation/Perfusion Imaging for the Prediction of Postoperative Residual Pulmonary Function | ||
| NCT06563245 | Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment | ||
| NCT01405079 | Gefitinib Versus Vinorelbine/Platinum as Adjuvant Treatment in Stage II-IIIA(N1-N2) NSCLC With EGFR Mutation | ||
| NCT07383142 | Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2) | ||
| NCT07269574 | Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance | ||
| NCT06509919 | Application of a Novel Biomarker Based on Plasma cfDNA Assay in the Early Diagnosis of Prostate Cancer | ||
| NCT07454941 | Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics | ||
| NCT04320979 | Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients | ||
| NCT04012645 | Perfusion Outcomes With Near Infrared-Indocyanine Green Imaging System in Laparoscopic Total Mesorectal Excision for Mid- or Low-rectal CanceR | ||
| NCT01391572 | A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer | ||
| NCT03468712 | Laparoscopic D2 Distal Gastrectomy Following Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancers | ||
| NCT05464875 | A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors | ||
| NCT05105945 | Clinical Study on the Efficacy of Single-port Inflatable Mediastinoscopy Combined With Laparoscopic-assisted Small Incision Surgery and Thoracoscopy Combined With Laparoscopic Surgery for Radical Esophagectomy | ||
| NCT04519983 | Efficacy of SRT as Salvage Therapy in Patients With Brain Oligo-progression of EGFR-mutant Non-small Cell Lung Cancer After Failure of the Third-generation EGFR-TKIs | ||
| NCT07005999 | Interventional Ablation for Early-stage Lung Cancer | ||
| NCT03759275 | pMDT in Thoracic Surgery--------For the Baseline Investigation and Technical Preparation Stage | ||
| NCT05351346 | Genotype-guided Treatment in DLBCL | ||
| NCT06863831 | A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC | ||
| NCT02222753 | Immunological Markers Screening for Colorectal Cancer | ||
| NCT06679244 | Application of a New Surgical Technique in Proximal Gastrectomy: a Prospective, Multicenter Randomized Controlled Study | ||
| NCT01053390 | New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma | ||
| NCT07070193 | Longitudinal Cohort Study on Immune Thrombocytopenia Complicated With Acute Ischemic Stroke | ||
| NCT03013010 | PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy | ||
| NCT01455610 | Resectability of Pancreatic Head Cancer by Contrast-enhanced MDCT:a Multi-center Study | ||
| NCT04303247 | CD19 and CD22 Dual-targeted CAR-T Cells for Relapsed or Refractory B-NHL | ||
| NCT05907447 | A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types | ||
| NCT07312526 | Shanghai Clinical Cohort - Esophageal Cancer | ||
| NCT04517539 | Abscopal Effect of SBRT in Combination With rhGM-CSF and INF-α 2b for Metastatic Thymic Epithelial Tumors | ||
| NCT05759546 | PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast Cancer | ||
| NCT04881838 | CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL | ||
| NCT02630108 | TACE Combined With Synchronous Radiofrequency /Microwave Ablation to Treat Large and Huge Hepatocellular Carcinoma | ||
| NCT01398449 | Is ENI Necessary For Patients With Thoracic Esophageal Cancer After Esophagectomy And With Pathological Stage Of T1-2,N+,M0 | ||
| NCT04522687 | Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte Subsets Among Thoracic Cancer | ||
| NCT04638270 | Anti-CD19 FasT CAR-T Cell Therapy for B Cell NHL | ||
| NCT00631839 | Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury | ||
| NCT07370116 | Omitting Nasogastric Tube Decompression in Minimally Invasive Pancreaticoduodenectomy | ||
| NCT01243788 | The Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPD | ||
| NCT06686342 | PDO Based Drug Sensitive Test in R/M HNSCC | ||
| NCT05594095 | SNF Platform Study of HR+/ HER2-advanced Breast Cancer | ||
| NCT07375979 | A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational Study | ||
| NCT04923802 | Multi-Omics Testing for Immunotherapy Efficacy Evaluation (MOTIVATION) | ||
| NCT06440018 | INSPIRE: a Multi-Cancer Early Detection Study | ||
| NCT07168980 | Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents | ||
| NCT04140552 | Chinese Research Group of Gallbladder Cancer | ||
| NCT02216955 | Nutrition and Lifestyle Study Cohort of Gastric Cancer in China | ||
| NCT05598528 | Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study) |
